PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.52%
Revenue growth under 50% of BIDU's 11281.08%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.35%
Gross profit growth under 50% of BIDU's 4328.56%. Michael Burry would be concerned about a severe competitive disadvantage.
0.28%
EBIT growth below 50% of BIDU's 1253.04%. Michael Burry would suspect deeper competitive or cost structure issues.
0.28%
Operating income growth under 50% of BIDU's 1253.04%. Michael Burry would be concerned about deeper cost or sales issues.
-0.97%
Negative net income growth while BIDU stands at 5362.70%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-6.25%
Negative EPS growth while BIDU is at 5251.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
0.21%
Share reduction more than 1.5x BIDU's 0.64%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.14%
Diluted share reduction more than 1.5x BIDU's 0.74%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-5.40%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-6.58%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
11088.84%
10Y revenue/share CAGR above 1.5x BIDU's 3639.82%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
351.35%
5Y revenue/share CAGR under 50% of BIDU's 837.61%. Michael Burry would suspect a significant competitive gap or product weakness.
79.92%
3Y revenue/share CAGR under 50% of BIDU's 356.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
308.41%
OCF/share CAGR of 308.41% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
106.16%
3Y OCF/share CAGR of 106.16% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
16850.47%
Net income/share CAGR above 1.5x BIDU's 6448.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
343.27%
Below 50% of BIDU's 6262.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
89.81%
Below 50% of BIDU's 446.58%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
835.15%
Below 50% of BIDU's 32500.64%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
102.70%
Below 50% of BIDU's 252.63%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.66%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-38.08%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
5.86%
Asset growth at 75-90% of BIDU's 6.54%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
6.11%
50-75% of BIDU's 9.94%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
11.11%
R&D dropping or stable vs. BIDU's 1121.32%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-2.98%
We cut SG&A while BIDU invests at 176.57%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.